• Overview
    Overview
  • Revenue
    Revenue
  • Segments
    • Revenue by Product
    • Revenue by Region
    Segments
  • Financials
    • Income Statement
    • Balance Sheet
    • Cashflow Statements
    • Profitability
    • Ratios
    Financials
  • People
    • CEO Salary
    • Employees
    • Revenue per Employee
    • Net Income per Employee
    People
  • OwnershipOwnership
    Ownership
  • Competitors
    Competitors
  • Stocks
    • Market Cap
    • PE Ratio
    • Stock Split
    • Dividend
    Stocks
  • News
    • Company News
    • Press Releases
    News
  • Earnings Calls
    Earnings Calls
  • Documents
    • Annual Reports
    • Quarterly Reports
    • SEC Filings
    Documents
Submit Feedback
Submit Feedback (Sign in required)
Bullfincher logo
Recent searches
    Trending searches
    • Company logo Caterpillar Overview
    • Company logo Apple Revenue
    • Company logo NVIDIA Corporation Employees
    • Company logo Microsoft Corporati... Revenue by segment
    • Company logo Amazon.com Financials
    • Company logo Tesla Overview
    • Home
    • Companies
    • Calendars
    • Ranking
    • Blog
    • Login

    Submit feedback to Bullfincher

    BMY logo Bristol-Myers Squibb Company +
    BMY logo
    Bristol-Myers Squibb Company
    +
    • Overview
    • Revenue
    • Segments
      • Revenue by Product
      • Revenue by Region
    • Financials
      • Income Statement
      • Balance Sheet
      • Cashflow Statement
      • Profitability
      • Ratios
    • People
      • CEO Salary
      • Employees
      • Revenue per Employee
      • Net Income per Employee
    • Ownership
    • Competitors
    • Stocks
      • Market Cap
      • PE Ratio
      • Stock Split
      • Dividend
    • News
      • Company News
      • Press Releases
    • Earnings Calls
    • Documents
      • Annual Report 10K
      • Quarterly Report 10Q
      • SEC Filings
    BMY logo Bristol-Myers Squibb Company BMY + Follow
    • Revenue
    • Employees
    • Market Capitalization

    Bristol-Myers Squibb Company's Revenue (2016 - 2025)

    • Bristol-Myers Squibb Company's annual revenue was $48.19 B in fiscal year 2025. The annual revenue decreased -$106.00 M from $48.30 B (in 2024) to $48.19 B (in 2025), representing a -0.22% year-over-year decline.

    • Bristol-Myers Squibb Company's quarterly revenue was $11.49 B in the quarter ending Mar 2026. The quarterly revenue increased $288.00 M from $11.20 B (in Q1: Dec 2025) to $11.49 B (in Q1: Dec 2026), representing a 2.57% year-over-year growth.

    • Over the past 10 years (2016 - 2025):
    • The highest annual revenue for Bristol-Myers Squibb Company was $48.30 B in fiscal year 2024.
    • The lowest annual revenue was $19.43 B in fiscal year 2016.
    • The average revenue was $36.55 B.

    • Learn more about Bristol-Myers Squibb Company's Revenue by Segment and Revenue by Region.

      Check out competitors to Bristol-Myers Squibb Company in a side-by-side comparison.

      Explore additional financial metrics for Bristol-Myers Squibb Company.


      Definition of Revenue :
    • Revenue is the amount of money generated by a business from sales of its goods or services. Refer to our glossary for more details, examples, and formulas.
    Continue reading...

    Bristol-Myers Squibb Company's Revenue Trend

    2015 16560000000.00
    2016 19427000000.00
    2017 20776000000.00
    2018 22561000000.00
    2019 26145000000.00
    2020 42518000000.00
    2021 46385000000.00
    2022 46159000000.00
    2023 45006000000.00
    2024 48300000000.00
    2025 48194000000.00
    Mar 2016 4391000000.00
    Jun 2016 4871000000.00
    Sep 2016 4922000000.00
    Dec 2016 5243000000.00
    Mar 2017 4929000000.00
    Jun 2017 5144000000.00
    Sep 2017 5254000000.00
    Dec 2017 5449000000.00
    Mar 2018 5193000000.00
    Jun 2018 5704000000.00
    Sep 2018 5691000000.00
    Dec 2018 5973000000.00
    Mar 2019 5920000000.00
    Jun 2019 6273000000.00
    Sep 2019 6007000000.00
    Dec 2019 7945000000.00
    Mar 2020 10781000000.00
    Jun 2020 10129000000.00
    Sep 2020 10540000000.00
    Dec 2020 11068000000.00
    Mar 2021 11073000000.00
    Jun 2021 11703000000.00
    Sep 2021 11624000000.00
    Dec 2021 11985000000.00
    Mar 2022 11648000000.00
    Jun 2022 11887000000.00
    Sep 2022 11218000000.00
    Dec 2022 11406000000.00
    Mar 2023 11337000000.00
    Jun 2023 11226000000.00
    Sep 2023 10966000000.00
    Dec 2023 11477000000.00
    Mar 2024 11865000000.00
    Jun 2024 12201000000.00
    Sep 2024 11892000000.00
    Dec 2024 12342000000.00
    Mar 2025 11201000000.00
    Jun 2025 12269000000.00
    Sep 2025 12222000000.00
    Dec 2025 12502000000.00
    Mar 2026 11489000000.00

    2025

    Bristol-Myers Squibb Company's annual revenue was $48.19 B in fiscal year 2025.

    Bristol-Myers Squibb Company's quarterly revenue was $11.20 B(Q1: Mar 2025), $12.27 B(Q2: Jun 2025), $12.22 B(Q3: Sep 2025), $12.50 B(Q4: Dec 2025) in fiscal year 2025.

    2024

    Bristol-Myers Squibb Company's annual revenue was $48.30 B in fiscal year 2024.

    Bristol-Myers Squibb Company's quarterly revenue was $11.87 B(Q1: Mar 2024), $12.20 B(Q2: Jun 2024), $11.89 B(Q3: Sep 2024), $12.34 B(Q4: Dec 2024) in fiscal year 2024.

    2023

    Bristol-Myers Squibb Company's annual revenue was $45.01 B in fiscal year 2023.

    Bristol-Myers Squibb Company's quarterly revenue was $11.34 B(Q1: Mar 2023), $11.23 B(Q2: Jun 2023), $10.97 B(Q3: Sep 2023), $11.48 B(Q4: Dec 2023) in fiscal year 2023.

    2022

    Bristol-Myers Squibb Company's annual revenue was $46.16 B in fiscal year 2022.

    Bristol-Myers Squibb Company's quarterly revenue was $11.65 B(Q1: Mar 2022), $11.89 B(Q2: Jun 2022), $11.22 B(Q3: Sep 2022), $11.41 B(Q4: Dec 2022) in fiscal year 2022.

    2021

    Bristol-Myers Squibb Company's annual revenue was $46.39 B in fiscal year 2021.

    Bristol-Myers Squibb Company's quarterly revenue was $11.07 B(Q1: Mar 2021), $11.70 B(Q2: Jun 2021), $11.62 B(Q3: Sep 2021), $11.99 B(Q4: Dec 2021) in fiscal year 2021.

    2020

    Bristol-Myers Squibb Company's annual revenue was $42.52 B in fiscal year 2020.

    Bristol-Myers Squibb Company's quarterly revenue was $10.78 B(Q1: Mar 2020), $10.13 B(Q2: Jun 2020), $10.54 B(Q3: Sep 2020), $11.07 B(Q4: Dec 2020) in fiscal year 2020.

    2019

    Bristol-Myers Squibb Company's annual revenue was $26.15 B in fiscal year 2019.

    Bristol-Myers Squibb Company's quarterly revenue was $5.92 B(Q1: Mar 2019), $6.27 B(Q2: Jun 2019), $6.01 B(Q3: Sep 2019), $7.95 B(Q4: Dec 2019) in fiscal year 2019.

    2018

    Bristol-Myers Squibb Company's annual revenue was $22.56 B in fiscal year 2018.

    Bristol-Myers Squibb Company's quarterly revenue was $5.19 B(Q1: Mar 2018), $5.70 B(Q2: Jun 2018), $5.69 B(Q3: Sep 2018), $5.97 B(Q4: Dec 2018) in fiscal year 2018.

    2017

    Bristol-Myers Squibb Company's annual revenue was $20.78 B in fiscal year 2017.

    Bristol-Myers Squibb Company's quarterly revenue was $4.93 B(Q1: Mar 2017), $5.14 B(Q2: Jun 2017), $5.25 B(Q3: Sep 2017), $5.45 B(Q4: Dec 2017) in fiscal year 2017.

    2016

    Bristol-Myers Squibb Company's annual revenue was $19.43 B in fiscal year 2016.

    Bristol-Myers Squibb Company's quarterly revenue was $4.39 B(Q1: Mar 2016), $4.87 B(Q2: Jun 2016), $4.92 B(Q3: Sep 2016), $5.24 B(Q4: Dec 2016) in fiscal year 2016.

    Continue reading...

    Bristol-Myers Squibb Company's Revenue (Year-over-Year Change)

    2015 0
    2016 +17.31
    2017 +6.94
    2018 +8.59
    2019 +15.89
    2020 +62.62
    2021 +9.09
    2022 -0.49
    2023 -2.50
    2024 +7.32
    2025 -0.22
    Q1: Mar 16 8.66
    Q2: Jun 16 17.01
    Q3: Sep 16 20.96
    Q4: Dec 16 22.30
    Q1: Mar 17 12.25
    Q2: Jun 17 5.60
    Q3: Sep 17 6.75
    Q4: Dec 17 3.93
    Q1: Mar 18 5.36
    Q2: Jun 18 10.89
    Q3: Sep 18 8.32
    Q4: Dec 18 9.62
    Q1: Mar 19 14.00
    Q2: Jun 19 9.98
    Q3: Sep 19 5.55
    Q4: Dec 19 33.02
    Q1: Mar 20 82.11
    Q2: Jun 20 61.47
    Q3: Sep 20 75.46
    Q4: Dec 20 39.31
    Q1: Mar 21 2.71
    Q2: Jun 21 15.54
    Q3: Sep 21 10.28
    Q4: Dec 21 8.29
    Q1: Mar 22 5.19
    Q2: Jun 22 1.57
    Q3: Sep 22 -3.49
    Q4: Dec 22 -4.83
    Q1: Mar 23 -2.67
    Q2: Jun 23 -5.56
    Q3: Sep 23 -2.25
    Q4: Dec 23 0.62
    Q1: Mar 24 4.66
    Q2: Jun 24 8.69
    Q3: Sep 24 8.44
    Q4: Dec 24 7.54
    Q1: Mar 25 -5.60
    Q2: Jun 25 0.56
    Q3: Sep 25 2.77
    Q4: Dec 25 1.30
    Q1: Mar 26 2.57

    2025

    Bristol-Myers Squibb Company’s annual revenue decreased -0.22% during fiscal year 2025 compared to 2024. It represents a decline of $106.00 M from $48.30 B (in 2024) to $48.19 B (in 2025).

    2024

    Bristol-Myers Squibb Company’s annual revenue increased +7.32% during fiscal year 2024 compared to 2023. It represents a growth of $3.29 B from $45.01 B (in 2023) to $48.30 B (in 2024).

    2023

    Bristol-Myers Squibb Company’s annual revenue decreased -2.50% during fiscal year 2023 compared to 2022. It represents a decline of $1.15 B from $46.16 B (in 2022) to $45.01 B (in 2023).

    2022

    Bristol-Myers Squibb Company’s annual revenue decreased -0.49% during fiscal year 2022 compared to 2021. It represents a decline of $226.00 M from $46.39 B (in 2021) to $46.16 B (in 2022).

    2021

    Bristol-Myers Squibb Company’s annual revenue increased +9.09% during fiscal year 2021 compared to 2020. It represents a growth of $3.87 B from $42.52 B (in 2020) to $46.39 B (in 2021).

    2020

    Bristol-Myers Squibb Company’s annual revenue increased +62.62% during fiscal year 2020 compared to 2019. It represents a growth of $16.37 B from $26.15 B (in 2019) to $42.52 B (in 2020).

    2019

    Bristol-Myers Squibb Company’s annual revenue increased +15.89% during fiscal year 2019 compared to 2018. It represents a growth of $3.58 B from $22.56 B (in 2018) to $26.15 B (in 2019).

    2018

    Bristol-Myers Squibb Company’s annual revenue increased +8.59% during fiscal year 2018 compared to 2017. It represents a growth of $1.79 B from $20.78 B (in 2017) to $22.56 B (in 2018).

    2017

    Bristol-Myers Squibb Company’s annual revenue increased +6.94% during fiscal year 2017 compared to 2016. It represents a growth of $1.35 B from $19.43 B (in 2016) to $20.78 B (in 2017).

    2016

    Bristol-Myers Squibb Company’s annual revenue increased +17.31% during fiscal year 2016 compared to 2015. It represents a growth of $2.87 B from $16.56 B (in 2015) to $19.43 B (in 2016).

    Continue reading...

    Bristol-Myers Squibb Company Revenue History

    Sign in to download table

    Period Revenue Year-over-Year Change

    Get instant access to data, Sign up for free

    FY 2025
    $48.19 B -$106.00 M 0.22%
    Q4: Dec 25 $12.50 B $160.00 M 1.3%
    Q3: Sep 25 $12.22 B $330.00 M 2.77%
    Q2: Jun 25 $12.27 B $68.00 M 0.56%
    Q1: Mar 25 $11.20 B -$664.00 M 5.6%

    Get instant access to data, Sign up for free

    FY 2024
    $48.30 B $3.29 B 7.32%
    Q4: Dec 24 $12.34 B $865.00 M 7.54%
    Q3: Sep 24 $11.89 B $926.00 M 8.44%
    Q2: Jun 24 $12.20 B $975.00 M 8.69%
    Q1: Mar 24 $11.87 B $528.00 M 4.66%

    Get instant access to data, Sign up for free

    FY 2023
    $45.01 B -$1.15 B 2.5%
    Q4: Dec 23 $11.48 B $71.00 M 0.62%
    Q3: Sep 23 $10.97 B -$252.00 M 2.25%
    Q2: Jun 23 $11.23 B -$661.00 M 5.56%
    Q1: Mar 23 $11.34 B -$311.00 M 2.67%

    Get instant access to data, Sign up for free

    FY 2022
    $46.16 B -$226.00 M 0.49%
    Q4: Dec 22 $11.41 B -$579.00 M 4.83%
    Q3: Sep 22 $11.22 B -$406.00 M 3.49%
    Q2: Jun 22 $11.89 B $184.00 M 1.57%
    Q1: Mar 22 $11.65 B $575.00 M 5.19%

    Get instant access to data, Sign up for free

    FY 2021
    $46.39 B $3.87 B 9.09%
    Q4: Dec 21 $11.99 B $917.00 M 8.29%
    Q3: Sep 21 $11.62 B $1.08 B 10.28%
    Q2: Jun 21 $11.70 B $1.57 B 15.54%
    Q1: Mar 21 $11.07 B $292.00 M 2.71%

    Get instant access to data, Sign up for free

    FY 2020
    $42.52 B $16.37 B 62.62%
    Q4: Dec 20 $11.07 B $3.12 B 39.31%
    Q3: Sep 20 $10.54 B $4.53 B 75.46%
    Q2: Jun 20 $10.13 B $3.86 B 61.47%
    Q1: Mar 20 $10.78 B $4.86 B 82.11%

    Get instant access to data, Sign up for free

    FY 2019
    $26.15 B $3.58 B 15.89%
    Q4: Dec 19 $7.95 B $1.97 B 33.02%
    Q3: Sep 19 $6.01 B $316.00 M 5.55%
    Q2: Jun 19 $6.27 B $569.00 M 9.98%
    Q1: Mar 19 $5.92 B $727.00 M 14%

    Get instant access to data, Sign up for free

    FY 2018
    $22.56 B $1.79 B 8.59%
    Q4: Dec 18 $5.97 B $524.00 M 9.62%
    Q3: Sep 18 $5.69 B $437.00 M 8.32%
    Q2: Jun 18 $5.70 B $560.00 M 10.89%
    Q1: Mar 18 $5.19 B $264.00 M 5.36%

    Get instant access to data, Sign up for free

    FY 2017
    $20.78 B $1.35 B 6.94%
    Q4: Dec 17 $5.45 B $206.00 M 3.93%
    Q3: Sep 17 $5.25 B $332.00 M 6.75%
    Q2: Jun 17 $5.14 B $273.00 M 5.6%
    Q1: Mar 17 $4.93 B $538.00 M 12.25%

    Get instant access to data, Sign up for free

    FY 2016
    $19.43 B $2.87 B 17.31%
    Q4: Dec 16 $5.24 B $956.00 M 22.3%
    Q3: Sep 16 $4.92 B $853.00 M 20.96%
    Q2: Jun 16 $4.87 B $708.00 M 17.01%
    Q1: Mar 16 $4.39 B $350.00 M 8.66%

    Frequently Asked Questions

    What is the annual revenue of Bristol-Myers Squibb Company?

    In fiscal year 2025, Bristol-Myers Squibb Company's revenue was $48.19 Billion.

    How much did Bristol-Myers Squibb Company's revenue change in the last year?

    Bristol-Myers Squibb Company's revenue decreased by -0.22% (-$106.00 Million) in 2025 compared to 2024.

    What is Bristol-Myers Squibb Company's most recent quarterly revenue?

    In the first quarter (Q1) of 2026, Bristol-Myers Squibb Company reported a revenue of $11.49 Billion.

    What is Bristol-Myers Squibb Company's revenue per share (TTM)?

    Bristol-Myers Squibb Company's revenue per share over the trailing twelve months is $23.72.

    What is Bristol-Myers Squibb Company's revenue per employee?

    In the fiscal year 2025, Bristol-Myers Squibb Company's revenue per employee was $1.48 Million.

    What is the annual net income of Bristol-Myers Squibb Company?

    In fiscal year 2025, Bristol-Myers Squibb Company's net income was $7.05 Billion.

    What is Bristol-Myers Squibb Company's biggest product segment, and what is its revenue?

    Eliquis is Bristol-Myers Squibb Company's biggest product segment, generating $14.44 Billion in revenue for fiscal year 2025.

    What is Bristol-Myers Squibb Company's net income per employee?

    In the fiscal year 2025, Bristol-Myers Squibb Company's net income per employee was $217.02 K.

    Related

    • A logo Agilent Technologies Revenue
    • LLY logo Eli Lilly and Company Revenue
    • SYK logo Stryker Corporation Revenue
    • JNJ logo Johnson & Johnson Revenue
    • ABBV logo AbbVie Revenue
    • MRK logo Merck & Co. Revenue
    • TMO logo Thermo Fisher Scientific Revenue
    • ABT logo Abbott Laboratories Revenue
    • DHR logo Danaher Corporation Revenue

    People Also Search For

    • CAT logo Caterpillar
    • AAPL logo Apple
    • NVDA logo NVIDIA Corporation
    • MSFT logo Microsoft Corporation
    • AMZN logo Amazon.com
    • TSLA logo Tesla
    • GOOGL logo Alphabet (Google)
    • NKE logo NIKE
    • WMT logo Walmart
    • META logo Meta Platforms (Facebook)
    • PEP logo PepsiCo
    • TGT logo Target Corporation
    footer logo

    Bullfincher is a “visual-first” business intelligence and research platform. We believe that behind every great company, there is a great story. At Bullfincher, we make story-telling a little easier using dynamic visuals, charts, and graphs.

    explore
    • About Us
    • Blog
    • FAQ
    • Glossary
    Discover
    • Privacy Policy
    • Contact us
    • Submit Feedback
    • Advertise with Us
    Subscribe to our Newsletter !

    Don’t worry, we won’t spam you.

    Disclaimers - All data and information is provided “as is” for informational purposes only and is not intended for trading purposes or financial, investment, tax, legal, accounting, or other advice. Please consult your broker or financial representative to verify pricing before executing any trade. Bullfincher is not an investment adviser, financial adviser, or a securities broker.None of the data and information constitutes investment advice nor an offering, recommendation, or solicitation by Bullfincher to buy, sell, or hold any security or financial product, and Bullfincher makes no representation (and has no opinion) regarding the advisability or suitability of any investment.

    None of the data and information constitutes investment advice (whether general or customized). The financial products or operations referred to in such data and information may not be suitable for your investment profile and investment objectives or expectations. It is your responsibility to consider whether any financial product or operation is suitable foryou based on your interests, investment objectives, investment horizon, and risk appetite. Bullfincher shall not be liable for any damages arising from any operations or investments in financial products referred to within. Bullfincher does not recommend using the data and information provided as the only basis for making any investment decision.

    Bullfincher 2026, All rights reserved

    Submit feedback to Bullfincher

    Submit your feedback


    Note: Please upload only jpg and png file and size 5 MB allowed.